People

James F. Jordan

President and Chief Executive Officer

Jim Jordan is an accomplished Fortune 20-level executive with strong experience in industry, consulting and academia.  A recognized expert in translational innovation, market development, and guiding the successful formation of entrepreneurial startup businesses in the Life Sciences Industry, Mr. Jordan joined the PLSG in 2005, became Vice President and Chief Investment Officer in 2007, and was named President and Chief Executive Officer in 2016.

Prior to joining the PLSG, Mr. Jordan served as Senior Vice President of a $3.0 billion division of McKesson Corporation, a leading distributor of healthcare systems, medical supplies, and pharmaceutical products, and as a Vice President for Marketing at Johnson & Johnson, one of the world’s largest consumer products and healthcare companies.  He has held a range of management positions in sales and marketing, operations, supply chain management, information technology, finance, and quality assurance with several Fortune 500 medical device companies, including C.R. Bard, Inc. and Boston Scientific, Inc.  Mr. Jordan has leveraged this experience in several startup ventures and is active on several Boards of Directors, including the Pittsburgh Venture Capital Association.

Mr. Jordan’s experience, which also includes consulting engagements with numerous companies such as Medtronic, Frost & Sullivan, Circuit City, Philip Morris, Northrop Grumman, Schwartz Pharmaceutical, and Otsuka Pharmaceutical, is documented in his book, titled Innovation, Commercialization, and Start-ups in Life Sciences, published by CRC Press ©2015 by Taylor & Francis Group Ltd., which is available on www.amazon.com.  This university textbook details the necessary data, partnerships, and skills to be acquired and the constituencies that must be satisfied along the way to a successful exit.

Mr. Jordan previously served as an Adjunct Associate Professor at the Robins School of Business at University of Richmond, where he taught Introduction to Managing Projects, Advanced Project Management, PMP Certification Test Preparation and Project Risk Management.  Mr. Jordan joined Carnegie Mellon University’s Heinz College of Information Systems and Public Policy in 2005 and serves as Sr. Director and Distinguished Service Professor of Health Care and Biotechnology Programs, and also as Strategic Board Chairman-Center for Healthcare Innovation.  He holds a Bachelor of Science Degree in Business Administration from Merrimack College and a Master of Business Administration degree from Boston University.

Most recently, Mr. Jordan co-authored The Intellectual Property Pyramid Assessment: A Novel Method for Creating a Sustainable Competitive Advantage, a new workbook and method designed to help individuals, companies, investors, and patent attorneys develop comprehensive IP strategies, assess the strength of existing IP portfolios, and create a significant competitive advantage.  The IP workbook is soon to be published and will be available on www.amazon.com.

Diana Cugliari

Vice President, Finance
Director, Accelerator Fund

Diana Cugliari serves as Vice President of Finance for the Pittsburgh Life Sciences Greenhouse (PLSG) and Director of the Accelerator Fund, LLC, overseeing the complete financial operation of the organization.

Her experience in guiding portfolio companies, coupled with her sharp business acumen, has served her well during her time at the PLSG. Since joining in 2012, Ms. Cugliari has filled many crucial roles within the business, having assisted in grant proposal writing, branding and marketing, incubator management, IT network management, and controller duties, among other tasks.

Prior to assuming the post of VP of Finance for PLSG overall, Ms. Cugliari had served as Associate Director of the Accelerator Fund, an early-stage venture capital fund focused on high impact investments in the life sciences and health care sectors. Ms. Cugliari’s most recent prior position was Senior Investment Manager, responsible for providing strategic and tactical guidance during a company’s crucial formative stages while also assisting in the fundamental business strategy for PLSG’s growing portfolio company roster. In addition, she identified funding strategies and sources of potential capital.

Prior to her time at the PLSG, Ms. Cugliari ran The Money Tree Financial Corporation, a startup providing mortgage banking products and solutions. She expanded the company footprint from a one-state licensed mortgage broker to a 10-state mortgage banking operation, generating annual sales in excess of $170 million.

Ms. Cugliari earned her Bachelor of Arts in Economics from the University of Pittsburgh and her Master of Business Administration degree from the Joseph M. Katz Graduate School of Business, University of Pittsburgh.

Diane Hill

Senior Investment Manager

Diane Hill is a highly creative marketing professional with 20+ years of experience providing strategic marketing solutions to the Medical Industry. She has built a successful consulting practice, LDI Marketing, Inc., and is currently working with the Pittsburgh Life Sciences Greenhouse to assist organizations with their strategic marketing needs. Ms. Hill is an independent thinker who thrives in unknown territory, quick to assess market opportunities, and excels at market analysis. Whether product positioning, re-branding or creating new market niches for mature products, she has consistently delivered bottom line results for her clients. Ms. Hill’s background includes domestic and international product marketing, with extensive clinical experience and physician interaction. She has successfully managed a $100M product line and 75-member global team. Advertising agency experience has enhanced this marketing management know-how; working directly with clients to develop strategic marketing plans, brand development, and creative campaigns consistent with business objectives. Ms. Hill has held a range of positions in sales and marketing management with several Fortune 100 companies including: Baxter Healthcare Corporation, American Hospital Supply, C.R. Bard Corporation and Electronic Data Systems. She has also work for several medically focused advertising agencies, including Interpublic Group. Ms. Hill has consulted with numerous companies including: Regeneration Technologies, McKesson Corporation, Johnson & Johnson, Boston Scientific, and Medtronic. She has provided strategic direction for many start-up ventures, such as: InSitu Biologics, PneumRx, and CIRCA Scientific. Ms. Hill holds a Bachelor of Science degree in Business Administration from Central Michigan University and a Master of Business Administration degree from Michigan State University.

T. Marlise Manzetti

Accounting

Megan L. Mough

Executive Assistant to the CEO
Office Manager

As Executive Assistant to Jim Jordan and Office Manager at the Pittsburgh Life Sciences Greenhouse, Megan Mough brings the perfect blend of administrative expertise, business acumen, and familiarity with life sciences to the role.  She is responsible for providing assistance to the CEO to maximize his impact within the organization and the larger community.  Ms. Mough also works with the PLSG team and Board of Directors as needed in working with early stage therapy and medical device companies with the goal of helping those companies achieve successful commercialization.  Prior to joining the PLSG, Ms. Mough served in several roles in the Department of Neurobiology in the University of Pittsburgh School of Medicine, the most recent of which was that of Personnel Administrator.  She earned a BA in Communication Studies and Psychology from Duquesne University and a MBA with a concentration in Human Resources Management and Organizational Behavior from the Joseph M. Katz Graduate School of Business at the University of Pittsburgh.

Hank Safferstein, PhD, JD

Executive-In-Residence (EIR)

Dr. Safferstein joined the PLSG in 2007 and is now also Senior Vice President of Cognition Therapeutics, a PLSG portfolio company.   He served as Vice President of Business Development for Omrix Biopharmaceuticals, a commercial-stage company that develops and markets biosurgical and passive immunotherapy products. Prior to joining Omrix, he was Executive Vice President of Corporate Development for TransPharma Medical, a privately-held medical device company. From 2001 to 2005, Dr. Safferstein was Vice President of Business Development for Acorda Therapeutics, a central nervous system drug development and marketing company. Prior to joining Acorda Therapeutics, Dr. Safferstein served in various business development and marketing positions with Bristol-Myers Squibb, a multinational pharmaceutical company.  From 1991-1997, he was Director of Technology Transfer at the National Heart, Lung, and Blood Institute and Cooperative Venture Manager for the National Institute of Allergy and Infectious Diseases, National Institutes of Health. Dr. Safferstein was an NIH Post-Doctoral Fellow and Fellow of the Multiple Sclerosis Society.

He received a BA in Biochemistry from Rutgers University, a PhD in Human Anatomy and Neurobiology from the University of Louisville, a JD from the American University, Washington College of Law and an MBA from Columbia University.

Alan West

Executive-in-Residence (EIR)

Alan West re-joined PLSG in 2017 as a Resident Entrepreneur following a successful career as CEO of Carmell Therapeutics, a PLSG portfolio company.  He served as an EIR at the PLSG from 2005 to 2009, working with over 40 entrepreneurs and start-ups.  He has more than 25 years of experience in managing medical device start-up companies with a track record that includes both large and small companies, including Johnson & Johnson, Advanced Mechanical Technologies, Boston Scientific Corporation (Microvasive), Vision Sciences Inc. (endoscopy company), and Assurance Medical Inc.(surgical oncology company).

He was VP of R&D at Boston Scientific prior to their successful IPO, has a broad technical and business background, and has developed and marketed products in the radiology, cardiology, vascular surgery, dermatology, neurosurgery, gastroenterology, oncology, general surgery, sports medicine, and orthopedic markets. In his career, he has raised more than $50M through private and public offerings and holds numerous patents and has published articles in scientific, medical, and history journals.

Mr. West also gained experience in technology-based economic development, company commercialization, and incubator management at the Michigan Tech SmartZone, where he was founder and CEO. He holds a bachelor’s degree in Mechanical Engineering from Brown University and a master’s in Design from Tufts University.